{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:52:54Z","timestamp":1761663174463},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,12,15]]},"DOI":"10.1097\/qai.0b013e3182a06eb6","type":"journal-article","created":{"date-parts":[[2013,6,22]],"date-time":"2013-06-22T14:34:03Z","timestamp":1371911643000},"page":"434-442","source":"Crossref","is-referenced-by-count":6,"title":["Prediction of Hepatic Fibrosis in Patients Coinfected With HIV and Hepatitis C Virus Based on Genetic Markers"],"prefix":"10.1097","volume":"64","author":[{"given":"Amanda","family":"Fern\u00e1ndez-Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Berenguer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda A.","family":"Jim\u00e9nez-Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Guzm\u00e1n-Fulgencio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dariela","family":"Micheloud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Miralles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Bell\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Aldamiz-Echevarria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Garc\u00eda\u2013Broncano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Carrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvador","family":"Resino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-2-20210131","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1473-3099(05)70216-4","article-title":"Global epidemiology of hepatitis C virus infection.","volume":"5","author":"Shepard","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"suppl 1","key":"R2-2-20210131","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1478-3231.2008.01927.x","article-title":"The history of the natural history of hepatitis C (1968-2009).","volume":"29","author":"Seeff","year":"2009","journal-title":"Liver Int"},{"key":"R4-2-20210131","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1365-2893.2011.01481.x","article-title":". Role of hepatitis C virus genotype 3 in liver fibrosis progressiona systematic review and meta-analysis.","volume":"18","author":"Probst","year":"2011","journal-title":"J Viral Hepat"},{"key":"R5-2-20210131","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/hep.22375","article-title":". Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression.","volume":"48","author":"Thein","year":"2008","journal-title":"Hepatology"},{"key":"R6-2-20210131","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1053\/j.gastro.2006.03.014","article-title":". Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.","volume":"130","author":"Leandro","year":"2006","journal-title":"Gastroenterology"},{"key":"R7-2-20210131","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1468-1293.2008.00686.x","article-title":". Liver-related deaths in HIV-infected patients between 1995 and 2005 in the French GERMIVIC Joint Study Group Network (Mortavic 2005 study in collaboration with the Mortalite 2005 survey, ANRS EN19).","volume":"10","author":"Rosenthal","year":"2009","journal-title":"HIV Med"},{"key":"R8-2-20210131","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1097\/QAD.0b013e32830e6d51","article-title":". Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis.","volume":"22","author":"Thein","year":"2008","journal-title":"AIDS"},{"issue":"suppl 1","key":"R9-2-20210131","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1478-3231.2010.02394.x","article-title":"The impact of human immunodeficiency virus on viral hepatitis.","volume":"31","author":"Mallet","year":"2011","journal-title":"Liver Int"},{"key":"R10-2-20210131","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.bpg.2010.07.013","article-title":"Liver fibrosis: from animal models to mapping of human risk variants.","volume":"24","author":"Weber","year":"2010","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R11-2-20210131","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.21695","article-title":". A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C.","volume":"46","author":"Huang","year":"2007","journal-title":"Hepatology"},{"key":"R12-2-20210131","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jhep.2009.04.027","article-title":". Multiple variants in toll-like receptor 4 gene modulate risk of liver fibrosis in Caucasians with chronic hepatitis C infection.","volume":"51","author":"Li","year":"2009","journal-title":"J Hepatol"},{"key":"R13-2-20210131","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/hep.22697","article-title":". Functional linkage of cirrhosis-predictive single nucleotide polymorphisms of toll-like receptor 4 to hepatic stellate cell responses.","volume":"49","author":"Guo","year":"2009","journal-title":"Hepatology"},{"key":"R14-2-20210131","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/FPC.0b013e32834c3e74","article-title":". Predicting cirrhosis and clinical outcomes in patients with advanced chronic hepatitis C with a panel of genetic markers (CRS7).","volume":"21","author":"Curto","year":"2011","journal-title":"Pharmacogenet and Genomics"},{"key":"R15-2-20210131","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jhep.2010.10.018","article-title":". Role of a cirrhosis risk score for the early prediction of fibrosis progression in hepatitis C patients with minimal liver disease.","volume":"55","author":"Trepo","year":"2011","journal-title":"J Hepatol"},{"key":"R16-2-20210131","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/hep.23111","article-title":". A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C.","volume":"50","author":"Marcolongo","year":"2009","journal-title":"Hepatology"},{"key":"R17-2-20210131","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1086\/501021","article-title":". Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.","volume":"42","author":"Barreiro","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R18-2-20210131","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3324\/haematol.2011.050351","article-title":". IL28B polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infection.","volume":"97","author":"Di Marco","year":"2012","journal-title":"Haematologica"},{"key":"R19-2-20210131","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1093\/infdis\/jir113","article-title":". Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy.","volume":"203","author":"Barreiro","year":"2011","journal-title":"J Infect Dis"},{"key":"R20-2-20210131","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jinf.2012.10.025","article-title":". IL28B polymorphisms are associated with severity of liver disease in human immunodeficiency virus (HIV) patients coinfected with hepatitis C virus.","volume":"66","author":"Guzman-Fulgencio","year":"2012","journal-title":"J Infect"},{"key":"R21-2-20210131","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/COH.0b013e32834bd257","article-title":"Current treatment for chronic hepatitis C virusHIV-infected individuals: the role of pegylated interferon-alpha and ribavirin.","volume":"6","author":"Bhagani","year":"2011","journal-title":"Curr Opin HIV AIDS"},{"key":"R22-2-20210131","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1177\/135965350801300303","article-title":". Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir.","volume":"13","author":"Vispo","year":"2008","journal-title":"Antivir Ther"},{"key":"R23-2-20210131","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/jac\/dkn420","article-title":". Efficacy of pegylated interferon plus ribavirin treatment in HIVhepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone.","volume":"62","author":"Mira","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"R24-2-20210131","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00002030-200401020-00008","article-title":". Pegylated interferon alpha2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients.","volume":"18","author":"Moreno","year":"2004","journal-title":"AIDS"},{"key":"R25-2-20210131","doi-asserted-by":"crossref","first-page":"F27","DOI":"10.1097\/00002030-200409030-00003","article-title":". Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIVHCV co-infected patients.","volume":"18","author":"Laguno","year":"2004","journal-title":"AIDS"},{"key":"R26-2-20210131","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1055\/s-0032-1316469","article-title":". Management and treatment of chronic hepatitis C in HIV patients.","volume":"32","author":"Barreiro","year":"2012","journal-title":"Semin Liver Dis"},{"key":"R27-2-20210131","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":". Diagnosis, management, and treatment of hepatitis C: an update.","volume":"49","author":"Ghany","year":"2009","journal-title":"Hepatology"},{"key":"R28-2-20210131","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/aje\/155.7.645","article-title":". Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment.","volume":"155","author":"Thorpe","year":"2002","journal-title":"Am J Epidemiol"},{"key":"R29-2-20210131","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1365-2893.2007.00881.x","article-title":". Identification of liver fibrosis in HIVHCV-coinfected patients using a simple predictive model based on routine laboratory data.","volume":"14","author":"Berenguer","year":"2007","journal-title":"J Viral Hepat"},{"key":"R30-2-20210131","doi-asserted-by":"crossref","first-page":"b604","DOI":"10.1136\/bmj.b604","article-title":". Prognosis and prognostic research: developing a prognostic model.","volume":"338","author":"Royston","year":"2009","journal-title":"BMJ"},{"key":"R31-2-20210131","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/lt.22475","article-title":"ON, Eurich D, Schmitz P, et al.. A 7-gene signature of the recipient predicts the progression of fibrosis after liver transplantation for hepatitis C virus infection.","volume":"18","year":"2012","journal-title":"Liver Transpl"},{"key":"R32-2-20210131","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1055\/s-0029-1191970","article-title":". Re-evaluation of the genetic cirrhosis risk score in patients with chronic hepatitis C virus infection.","volume":"47","author":"Grunhage","year":"2009","journal-title":"Z Gastroenterol"},{"key":"R33-2-20210131","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/jama.284.4.450","article-title":". The natural history of hepatitis C virus infection: host, viral, and environmental factors.","volume":"284","author":"Thomas","year":"2000","journal-title":"JAMA"},{"key":"R34-2-20210131","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/hep.23136","article-title":". Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virushepatitis C virus.","volume":"50","author":"Macias","year":"2009","journal-title":"Hepatology"},{"key":"R35-2-20210131","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1097\/QAD.0b013e3282f10de9","article-title":". Rapid fibrosis progression among HIVhepatitis C virus-co-infected adults.","volume":"21","author":"Sulkowski","year":"2007","journal-title":"AIDS"},{"key":"R36-2-20210131","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":". A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"R37-2-20210131","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":". Development of a simple noninvasive index to predict significant fibrosis in patients with HIVHCV coinfection.","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"R38-2-20210131","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jhep.2010.03.022","article-title":". Common variation of IL28 affects gamma-GTP levels and inflammation of the liver in chronically infected hepatitis C virus patients.","volume":"53","author":"Abe","year":"2010","journal-title":"J Hepatol"},{"key":"R39-2-20210131","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/hep.24678","article-title":". IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes.","volume":"55","author":"Bochud","year":"2011","journal-title":"Hepatology"},{"key":"R40-2-20210131","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1136\/gut.2010.222976","article-title":"Interferon lambdas: the next cytokine storm.","volume":"60","author":"Kelly","year":"2011","journal-title":"Gut"},{"key":"R41-2-20210131","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1053\/j.gastro.2011.12.055","article-title":". HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons.","volume":"142","author":"Thomas","year":"2012","journal-title":"Gastroenterology"},{"key":"R42-2-20210131","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jhep.2009.05.016","article-title":". Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C.","volume":"51","author":"Bochud","year":"2009","journal-title":"J Hepatol"},{"key":"R43-2-20210131","doi-asserted-by":"crossref","first-page":"e29370","DOI":"10.1371\/journal.pone.0029370","article-title":". Impact of IL28B-related single nucleotide polymorphisms on liver histopathology in chronic hepatitis C genotype 2 and 3.","volume":"7","author":"Rembeck","year":"2012","journal-title":"PLoS One"},{"key":"R44-2-20210131","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7150\/ijms.3.47","article-title":"The natural history of hepatitis C virus (HCV) infection.","volume":"3","author":"Chen","year":"2006","journal-title":"Int J Med Sci"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAI.0b013e3182a06eb6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T20:03:37Z","timestamp":1715544217000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-201312150-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,15]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e3182a06eb6","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12,15]]}}}